SlideShare a Scribd company logo
Understanding and using
WHO Medical Eligibility Criteria for
Contraceptive Use
(WHO MEC, 2010)
Prof. Aboubakr Elnashar
elnashar53@hotmail.com
Objective
Understanding and using
Tables
Wheel
Contraceptive Method Choice
1. Safety
2. Effectiveness
3. Availability (accessibility and affordability)
4. Acceptability.
Copper
IUD
Levonor
gestrel
IUD
ImplantInjectionPOPCombined
pill;
Patch
Ring
 Based on the current scientific evidence
 Category 1: Safe
No restriction for use
 Category 2: Usable
Advantages outweigh risks (theoretical or proven):
careful follow-up may be required
 Category 3: Not recommended
Risks(theoretical or proven) outweigh advantages
 Category 4: No use
Unaccepted health risk
I= Initiation of contraception
C= Continuation of contraception, NA= Not applicable
Breastfeeding: CHC
 < 1 month postpartum:
Category 3
 >1 month postpartum:
Category 2
DVT & PE: CHC
Acute DVT/PE: Category 4
DVT/PE on anticoagulant
for at least 3 months
 Higher risk of recurrence
Thrombophilia
Cancer
Recurrence
: Category 4
 Lower risk of recurrence
: Category 3
Bariatric Surgery: CHC
 Restrictive procedures:
(gastric band or sleeve):
Category 1
 Malabsorptive procedures
Malabsorption from method or SE of long term
vomiting/diarrhea
: COCs: Category 3
: P/Ring: Category 1
Hypertension: CHC
 Adequately controlled:
Category 3
 Elevated BP levels:
S 140-159 OR D 90-99
: Category 3
S > 160 OR D > 100
: Category 4
 Vascular disease: Category 4
 Hypertension during
pregnancy: Category 2
Obesity: CHC
 BMI > 30: Category 2
{Possible increased risk
of VTE, MI, stroke}
Rheumatic Diseases: CHC
 SLE
 Positive or unknown
APL antibodies: C4
 Thrombocytopenia: C2
 Immunosuppression: C2
 None of above: C2
 Rheumatoid Arthritis
 Immunosuppression:
C2
 Non-suppressed: C2
Age: CHC
Menarche to <40 years:
Category 1
> 40 years old: Category 2
Smoking: CHC
<35 and smoke: 2
>35 and smoke <15/day: 3
>35 and smoke > 15/day: 4
Thank you
Aboubakr Elnashar

More Related Content

What's hot

MANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANI
MANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANIMANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANI
MANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
Hepatitis and pregnancy warda
Hepatitis and pregnancy wardaHepatitis and pregnancy warda
Hepatitis and pregnancy warda
Osama Warda
 
Maternal Mortality
Maternal MortalityMaternal Mortality
Maternal Mortality
Arvind Kushwaha
 
Antenatal Corticosteroids
Antenatal Corticosteroids Antenatal Corticosteroids
Antenatal Corticosteroids
Aboubakr Elnashar
 
Abortion and post abortion care
Abortion and post abortion careAbortion and post abortion care
Abortion and post abortion care
Mesfin Mulugeta
 
100 picture osce in obstetrics and gynaecology
100 picture osce in obstetrics and gynaecology100 picture osce in obstetrics and gynaecology
100 picture osce in obstetrics and gynaecology
Aloy Okechukwu Ugwu
 
Overview of IUGR FGR
Overview of IUGR FGROverview of IUGR FGR
Overview of IUGR FGR
Dr.Laxmi Agrawal Shrikhande
 
antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing
Dr Praman Kushwah
 
Injectable contraceptives
Injectable contraceptivesInjectable contraceptives
Injectable contraceptivesraj kumar
 
Obstructed labour
Obstructed labourObstructed labour
Obstructed labour
Priyanka Gohil
 
Maternal Mortality
Maternal MortalityMaternal Mortality
Maternal Mortality
limgengyan
 
Pre conception care
Pre conception carePre conception care
Pre conception care
ELIZEBETH RANI V
 
Dr rabi postpartum contraception
Dr rabi postpartum contraceptionDr rabi postpartum contraception
Dr rabi postpartum contraception
Rabi Satpathy
 
Hepatitis B in Pregnancy
Hepatitis B in PregnancyHepatitis B in Pregnancy
Hepatitis B in Pregnancy
Aboubakr Elnashar
 
Vaccination and pregnancy
Vaccination and pregnancyVaccination and pregnancy
Vaccination and pregnancy
Aboubakr Elnashar
 
ole of LNG IUS in management of AUB (Levonorgestrel intrauterine system)Pres...
ole of LNG IUS in management of AUB(Levonorgestrel intrauterine system)Pres...ole of LNG IUS in management of AUB(Levonorgestrel intrauterine system)Pres...
ole of LNG IUS in management of AUB (Levonorgestrel intrauterine system)Pres...
Lifecare Centre
 
Preconceptional counselling
Preconceptional counsellingPreconceptional counselling
Preconceptional counselling
obgymgmcri
 
Female sterlization
Female sterlizationFemale sterlization
Female sterlization
Dr Meenakshi Sharma
 
Pre mature rupture of membrene
Pre mature rupture of membrenePre mature rupture of membrene
Pre mature rupture of membrene
Krupa Meet Patel
 

What's hot (20)

MANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANI
MANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANIMANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANI
MANAGEMENT OF VAULT PROLAPSE BY DR SHASHWAT JANI
 
Hepatitis and pregnancy warda
Hepatitis and pregnancy wardaHepatitis and pregnancy warda
Hepatitis and pregnancy warda
 
Maternal Mortality
Maternal MortalityMaternal Mortality
Maternal Mortality
 
Antenatal Corticosteroids
Antenatal Corticosteroids Antenatal Corticosteroids
Antenatal Corticosteroids
 
Abortion and post abortion care
Abortion and post abortion careAbortion and post abortion care
Abortion and post abortion care
 
100 picture osce in obstetrics and gynaecology
100 picture osce in obstetrics and gynaecology100 picture osce in obstetrics and gynaecology
100 picture osce in obstetrics and gynaecology
 
Overview of IUGR FGR
Overview of IUGR FGROverview of IUGR FGR
Overview of IUGR FGR
 
antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing
 
Injectable contraceptives
Injectable contraceptivesInjectable contraceptives
Injectable contraceptives
 
Obstructed labour
Obstructed labourObstructed labour
Obstructed labour
 
Maternal Mortality
Maternal MortalityMaternal Mortality
Maternal Mortality
 
management of placenta previa
management of placenta previamanagement of placenta previa
management of placenta previa
 
Pre conception care
Pre conception carePre conception care
Pre conception care
 
Dr rabi postpartum contraception
Dr rabi postpartum contraceptionDr rabi postpartum contraception
Dr rabi postpartum contraception
 
Hepatitis B in Pregnancy
Hepatitis B in PregnancyHepatitis B in Pregnancy
Hepatitis B in Pregnancy
 
Vaccination and pregnancy
Vaccination and pregnancyVaccination and pregnancy
Vaccination and pregnancy
 
ole of LNG IUS in management of AUB (Levonorgestrel intrauterine system)Pres...
ole of LNG IUS in management of AUB(Levonorgestrel intrauterine system)Pres...ole of LNG IUS in management of AUB(Levonorgestrel intrauterine system)Pres...
ole of LNG IUS in management of AUB (Levonorgestrel intrauterine system)Pres...
 
Preconceptional counselling
Preconceptional counsellingPreconceptional counselling
Preconceptional counselling
 
Female sterlization
Female sterlizationFemale sterlization
Female sterlization
 
Pre mature rupture of membrene
Pre mature rupture of membrenePre mature rupture of membrene
Pre mature rupture of membrene
 

Similar to Contraception elligability criteria WHO: Aboubakr Elnashar

Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSNikole Gettings
 
Session 2 implanon next training module
Session 2 implanon next training moduleSession 2 implanon next training module
Session 2 implanon next training module
bausher willayat
 
Antibiotic usage in pregnancy
Antibiotic usage in pregnancyAntibiotic usage in pregnancy
Antibiotic usage in pregnancy
Dr Meenakshi Sharma
 
drugseffectonthepregnancy-170219000730.pdf
drugseffectonthepregnancy-170219000730.pdfdrugseffectonthepregnancy-170219000730.pdf
drugseffectonthepregnancy-170219000730.pdf
Abisha62
 
Drugs effect on the pregnancy
Drugs effect on the pregnancyDrugs effect on the pregnancy
Drugs effect on the pregnancy
wisam alsaedi
 
Safe Prescribing of Second Line Combined Oral Contraceptive
Safe Prescribing of Second Line Combined Oral ContraceptiveSafe Prescribing of Second Line Combined Oral Contraceptive
Safe Prescribing of Second Line Combined Oral Contraceptivemeducationdotnet
 
Imaging in prgnancy
Imaging in prgnancyImaging in prgnancy
Imaging in prgnancy
chaimingcheng
 
143 e cpg3-april2004
143 e cpg3-april2004143 e cpg3-april2004
143 e cpg3-april2004
Luis Carlos Murillo Valencia
 
Colditz AACR prevention award lecture: preventing breast cancer now
Colditz AACR prevention award lecture: preventing breast cancer nowColditz AACR prevention award lecture: preventing breast cancer now
Colditz AACR prevention award lecture: preventing breast cancer now
Graham Colditz
 
Post abortal contraception
Post abortal contraceptionPost abortal contraception
Post abortal contraception
sarojsingh68
 
A comparative analysis of first trimester medical abortion in cases with prev...
A comparative analysis of first trimester medical abortion in cases with prev...A comparative analysis of first trimester medical abortion in cases with prev...
A comparative analysis of first trimester medical abortion in cases with prev...
International Multispeciality Journal of Health
 
post abortion.pptx
post abortion.pptxpost abortion.pptx
post abortion.pptx
Tiktokethiodaily
 
Treatment Options Stage III Colon Cancer - CRCWebinar June 21 2017
Treatment Options Stage III Colon Cancer - CRCWebinar June 21 2017Treatment Options Stage III Colon Cancer - CRCWebinar June 21 2017
Treatment Options Stage III Colon Cancer - CRCWebinar June 21 2017
Fight Colorectal Cancer
 
Evidence of drug safety in pregnancy.pdf
Evidence of drug safety in pregnancy.pdfEvidence of drug safety in pregnancy.pdf
Evidence of drug safety in pregnancy.pdf
Prof. Dr Pharmacology
 
GO MOMS Contraception by Andrea Henkel
GO MOMS Contraception by Andrea Henkel GO MOMS Contraception by Andrea Henkel
GO MOMS Contraception by Andrea Henkel
alucia2
 
마더리스크라운드 - Steroid in pregnancy
마더리스크라운드 - Steroid in pregnancy마더리스크라운드 - Steroid in pregnancy
마더리스크라운드 - Steroid in pregnancymothersafe
 
Immunization_in_Pregnancy (1).pdf
Immunization_in_Pregnancy (1).pdfImmunization_in_Pregnancy (1).pdf
Immunization_in_Pregnancy (1).pdf
Raaj Kumar
 
Evaluation of new approaches
Evaluation of new approachesEvaluation of new approaches
Evaluation of new approachesNARENDRA MALHOTRA
 

Similar to Contraception elligability criteria WHO: Aboubakr Elnashar (20)

Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
 
Session 2 implanon next training module
Session 2 implanon next training moduleSession 2 implanon next training module
Session 2 implanon next training module
 
Antibiotic usage in pregnancy
Antibiotic usage in pregnancyAntibiotic usage in pregnancy
Antibiotic usage in pregnancy
 
Contraception
ContraceptionContraception
Contraception
 
drugseffectonthepregnancy-170219000730.pdf
drugseffectonthepregnancy-170219000730.pdfdrugseffectonthepregnancy-170219000730.pdf
drugseffectonthepregnancy-170219000730.pdf
 
Drugs effect on the pregnancy
Drugs effect on the pregnancyDrugs effect on the pregnancy
Drugs effect on the pregnancy
 
Ind madina
Ind madinaInd madina
Ind madina
 
Safe Prescribing of Second Line Combined Oral Contraceptive
Safe Prescribing of Second Line Combined Oral ContraceptiveSafe Prescribing of Second Line Combined Oral Contraceptive
Safe Prescribing of Second Line Combined Oral Contraceptive
 
Imaging in prgnancy
Imaging in prgnancyImaging in prgnancy
Imaging in prgnancy
 
143 e cpg3-april2004
143 e cpg3-april2004143 e cpg3-april2004
143 e cpg3-april2004
 
Colditz AACR prevention award lecture: preventing breast cancer now
Colditz AACR prevention award lecture: preventing breast cancer nowColditz AACR prevention award lecture: preventing breast cancer now
Colditz AACR prevention award lecture: preventing breast cancer now
 
Post abortal contraception
Post abortal contraceptionPost abortal contraception
Post abortal contraception
 
A comparative analysis of first trimester medical abortion in cases with prev...
A comparative analysis of first trimester medical abortion in cases with prev...A comparative analysis of first trimester medical abortion in cases with prev...
A comparative analysis of first trimester medical abortion in cases with prev...
 
post abortion.pptx
post abortion.pptxpost abortion.pptx
post abortion.pptx
 
Treatment Options Stage III Colon Cancer - CRCWebinar June 21 2017
Treatment Options Stage III Colon Cancer - CRCWebinar June 21 2017Treatment Options Stage III Colon Cancer - CRCWebinar June 21 2017
Treatment Options Stage III Colon Cancer - CRCWebinar June 21 2017
 
Evidence of drug safety in pregnancy.pdf
Evidence of drug safety in pregnancy.pdfEvidence of drug safety in pregnancy.pdf
Evidence of drug safety in pregnancy.pdf
 
GO MOMS Contraception by Andrea Henkel
GO MOMS Contraception by Andrea Henkel GO MOMS Contraception by Andrea Henkel
GO MOMS Contraception by Andrea Henkel
 
마더리스크라운드 - Steroid in pregnancy
마더리스크라운드 - Steroid in pregnancy마더리스크라운드 - Steroid in pregnancy
마더리스크라운드 - Steroid in pregnancy
 
Immunization_in_Pregnancy (1).pdf
Immunization_in_Pregnancy (1).pdfImmunization_in_Pregnancy (1).pdf
Immunization_in_Pregnancy (1).pdf
 
Evaluation of new approaches
Evaluation of new approachesEvaluation of new approaches
Evaluation of new approaches
 

More from Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
Aboubakr Elnashar
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
Aboubakr Elnashar
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
Aboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
Aboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
Aboubakr Elnashar
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
Aboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
Aboubakr Elnashar
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
Aboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
Aboubakr Elnashar
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
Aboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
Aboubakr Elnashar
 
Female infertility
Female infertility Female infertility
Female infertility
Aboubakr Elnashar
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
Aboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
Aboubakr Elnashar
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
Aboubakr Elnashar
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
Aboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
Aboubakr Elnashar
 

More from Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 

Recently uploaded

How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 

Recently uploaded (20)

How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 

Contraception elligability criteria WHO: Aboubakr Elnashar

  • 1. Understanding and using WHO Medical Eligibility Criteria for Contraceptive Use (WHO MEC, 2010) Prof. Aboubakr Elnashar elnashar53@hotmail.com
  • 3. Contraceptive Method Choice 1. Safety 2. Effectiveness 3. Availability (accessibility and affordability) 4. Acceptability.
  • 5.  Based on the current scientific evidence  Category 1: Safe No restriction for use  Category 2: Usable Advantages outweigh risks (theoretical or proven): careful follow-up may be required  Category 3: Not recommended Risks(theoretical or proven) outweigh advantages  Category 4: No use Unaccepted health risk
  • 6. I= Initiation of contraception C= Continuation of contraception, NA= Not applicable
  • 7.
  • 8. Breastfeeding: CHC  < 1 month postpartum: Category 3  >1 month postpartum: Category 2
  • 9.
  • 10.
  • 11. DVT & PE: CHC Acute DVT/PE: Category 4 DVT/PE on anticoagulant for at least 3 months  Higher risk of recurrence Thrombophilia Cancer Recurrence : Category 4  Lower risk of recurrence : Category 3
  • 12.
  • 13.
  • 14.
  • 15. Bariatric Surgery: CHC  Restrictive procedures: (gastric band or sleeve): Category 1  Malabsorptive procedures Malabsorption from method or SE of long term vomiting/diarrhea : COCs: Category 3 : P/Ring: Category 1
  • 16.
  • 17.
  • 18. Hypertension: CHC  Adequately controlled: Category 3  Elevated BP levels: S 140-159 OR D 90-99 : Category 3 S > 160 OR D > 100 : Category 4  Vascular disease: Category 4  Hypertension during pregnancy: Category 2
  • 19.
  • 20. Obesity: CHC  BMI > 30: Category 2 {Possible increased risk of VTE, MI, stroke}
  • 21.
  • 22.
  • 23.
  • 24. Rheumatic Diseases: CHC  SLE  Positive or unknown APL antibodies: C4  Thrombocytopenia: C2  Immunosuppression: C2  None of above: C2  Rheumatoid Arthritis  Immunosuppression: C2  Non-suppressed: C2
  • 25. Age: CHC Menarche to <40 years: Category 1 > 40 years old: Category 2 Smoking: CHC <35 and smoke: 2 >35 and smoke <15/day: 3 >35 and smoke > 15/day: 4
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.